By assessing postoperative risk of AKI through CPB duration first and then using urinary L-FABP or urinary L-FABP/creatinine ratio for prediction and early diagnosis of AKI can provide more cost-effective and accurate risk discrimination than using urinary L-FABP examination alone. This evidence concerns the gene FABP1 and acute kidney injury.